Article information
Full text is only aviable in PDF
Bibliografía
[1.]
Textbook of pleural diseases,
[2.]
V. Villena, E. López Encuentra, R. García-Luján, et al.
Clinical implications of appearance of pleural fluid at thoracentesis.
Chest, 125 (2004), pp. 156-159
[3.]
D.S. Cheng, R.M. Rodríguez, J. Rogers, et al.
Comparison of pleural fluid pH values obtained using blood gas machine, pH meter, and pH indicatorstrip.
Chest, 114 (1998), pp. 1368-1372
[4.]
D. Jiménez-Castro, G. Díaz, E. Pérez-Rodríguez, et al.
Modification of pleural fluid pH by local anesthesia.
Chest, 116 (1999), pp. 399-402
[5.]
J.E. Heffner, L.K. Brown, C. Barbieri, et al.
Pleural fluid chemical análisis in parapneumonic effusions. A metanalysis.
Am J Respir Crit CareMed, 151 (1995), pp. 1700-1708
[6.]
F. Rodríguez-Panadero, J. López Mejías.
Low glucose and pH levels in malignant pleural effusions. Diagnostic significance and prognostic value in respect to pleurodesis.
Am Rev Respir Dis, 139 (1989), pp. 663-667
[7.]
D. Jiménez, E. Pérez Rodríguez, G. Díaz, et al.
Determining the optimal number of specimens to obtain with needle biopsy of the pleura.
Respir Med, 96 (2002), pp. 14-17
[8.]
J.M. Porcel, M. Vives.
Etiology and pleural fluid characteristics of large and massive effusions.
Chest, 124 (2003), pp. 978-983
[9.]
J. Ferrer, J. Roldán, J. Teixidor, et al.
Predictors of pleural malignancy in patients with pleural effusion undergoing thoracoscopy.
Chest, 127 (2005), pp. 1017-1022
[10.]
J.S. Ferrer, X.G. Muñoz, R.M. Orriols, et al.
Evolution of idiopathic pleural effusion: a prospective, long-term follow-up study.
Chest, 109 (1996), pp. 1508-1513
[11.]
S. Romero Candeira, L. Hernández Blasco, S. Romero Brufao.
Trasudados frente a exudados pleurales. Criterios discriminantes. Causas de trasudado pleural y aproximación diagnóstica.
Enfermedades de la pleura. Monografías Neumomadrid, pp. 57-68
[12.]
S. Romero-Candeira, L. Hernández.
The separation of transudates and exudates with particular reference to the protein gradient.
Curr Opin Pulm Med, 10 (2004), pp. 294-298
[13.]
S.A. Sahn.
Management of complicated parapneumonic effusions.
Am Rev Respir Dis, 148 (1993), pp. 813-817
[14.]
K.Y. Chen, P.R. Hsueh, Y.S. Liaw, et al.
A 10-year experience with bacteriology of acute thoracic empyema: emphasis on Klebsiella pneumoniae in patients with diabetes mellitus.
Chest, 117 (2000), pp. 1685-1689
[15.]
N.A. Maskell, C.W.H. Davis, A.J. Nunn, et al.
U.K. controlled trial of intrapleural streptokinase for pleural infection.
N Engl J Med, 352 (2005), pp. 865-874
[16.]
C.W. Davies, S.E. Kearney, F.V. Gleeson, et al.
Predictors of outcome and long-term survival in patients with pleural infection.
Am J Respir Crit Care Med, 160 (1999), pp. 1682-1687
[17.]
N.A. Maskell, F.V. Gleeson, M. Darby, et al.
Diagnostically significant variations in pleural fluid pH in loculated parapneumonic effusions.
Chest, 126 (2004), pp. 2022-2024
[18.]
J.E. Heffner.
Indications for draining a parapneumonic effusion: an evidence-based approach.
Semin Respir Infect, 14 (1999), pp. 48-58
[19.]
G.L. Colice, A. Curtis, J. Deslauriers, et al.
Medical and surgical treatment of parapneumonic effusions: an evidence-based guideline.
Chest, 118 (2000), pp. 1158-1171
[20.]
R. Jordà Marcos, A. Torres Martí, F.J. Ariza Cardenal, et al.
Recomendaciones para el tratamiento de la neumonía intrahospitalaria grave.
Arch Bronconeumol, 40 (2004), pp. 518-533
[21.]
Grupo de Estudio de la Neumonía Adquirida en la Comunidad.
Normativas para el diagnóstico y el tratamiento de la neumonía adquirida en la comunidad. Sociedad Española de Neumología y Cirugía Torácica (SEPAR).
Arch Bronconeumol, 41 (2005), pp. 272-289
[22.]
L.R. Texeira, M.A. Villarino.
Antibiotic treatment of patients with pneumonia and pleural effusion.
Curr Opin Pulm Med, 4 (1998), pp. 230-234
[23.]
R. Cameron, H.R. Davies.
Intra-pleural fibrinolytic therapy versus conservative management in the treatment of parapneumonic effusions and empyema.
Cochrane Database Syst Rev, 2 (2004),
[24.]
R. Vidal, J. De Gracia, J. Ruiz, et al.
Estudio controlado de 637 pacientes con tuberculosis: diagnóstico y resultados terapéuticos con esquemas de 9 y 6 meses.
Med Clin (Barc), 87 (1986), pp. 368-370
[25.]
L. Valdés, D. Álvarez, E. San José, et al.
Tuberculous pleurisy: A study of 254 cases.
Arch Intern Med, 158 (1998), pp. 2017-2021
[26.]
S. Greco, E. Girardi, R. Masciangelo, et al.
Adenosine deaminase and interferon gamma measurements for the diagnosis of tuberculous pleurisy: a meta-analysis.
Int J Tuberc Lung Dis, 7 (2003), pp. 777-786
[27.]
L.J. Burgess, F.J. Maritz, I. Le Roux, et al.
Combined use of pleural adenosine deaminase with lymphocyte/neutrophil ratio. Increased specificity for the diagnosis of tuberculosis pleuritis.
Chest, 109 (1996), pp. 414-419
[28.]
L. Valdés, E. San José, D. Álvarez, et al.
Diagnosis of tuberculous pleurisy using the biologic parameters adenosine deaminase, lysozyme, and interferon gamma.
Chest, 103 (1993), pp. 458-465
[29.]
L. Valdés, E. San José, D. Álvarez, et al.
Adenosine deaminase (ADA) isoenzyme analysis in pleural effusions: diagnostic role and relevance to the origin of increased ADA in tuberculous pleurisy.
Eur Respir J, 9 (1996), pp. 747-751
[30.]
V. Villena, A. López-Encuentra, F. Pozo, et al.
Interferon gamma levels in pleural fluid for the diagnosis of tuberculosis.
Am J Med, 115 (2003), pp. 365-370
[31.]
S.K. Sharma, A. Banga.
Pleural fluid interferon-? and adenosine deaminase levels in tuberculosis pleural effusion: A cost-effectiveness analysis.
J Clin Lab Anal, 19 (2005), pp. 40-46
[32.]
M. Pai, L.L. Flores, A. Hubbard, et al.
Nucleid acid amplification tests in the diagnosis of tuberculous pleuritis: a systematic review and metaanalysis.
BMC Infectious Diseases, 4 (2004), pp. 6-20
[33.]
H.M. Blumberg, W.J. Burman, R.E. Chaisson, et al.
American Thoracic Society / Centers for Diseases Control and Prevention/Infectious Diseases Society of America: Treatment of tuberculosis.
Am J Respir Crit Care Med, 167 (2003), pp. 603-662
[34.]
Y.F. Lai, T.Y. Chao, Y.H. Wang, et al.
Pigtail drainage in the treatment of tuberculous pleural effusions: a randomised study.
Thorax, 58 (2003), pp. 149-152
[35.]
P.T. Matchaba, J. Volmink.
Steroids for treating tuberculous pleurisy (Cochrane Review).
The Cochrane Library, Update Software, (2001),
[36.]
S.A. Sahn, J.T. Good Jr.
Pleural fluid pH in malignant effusions. Diagnostic, prognostic, and therapeutic implications.
Ann Intern Med Med, 108 (1988), pp. 345-349
[37.]
B.B. Ceyhan, E. Demiralp, T. Celikel.
Analysis of pleural effusions using flow cytometry.
Respiration, 63 (1996), pp. 17-24
[38.]
V.B. Antony, R. Loddenkemper, P. Astoul, et al.
Management of malignant pleural effusions.
Am J Respir Crit Care Med, 162 (2000), pp. 1987-2001
[39.]
G. Antunes, E. Neville, J. Duffy, et al.
BTS guidelines for the management of malignant pleural effusions.
Thorax, 58 (2003), pp. II29-II38
[40.]
C. Escudero Bueno, M. García Clemente, B. Cuesta Castro, et al.
Cytologic and bacteriologic analysis of fluid and pleural biopsy specimens with Cope’s needle. Study of 414 patients.
Arch Inter Med, 150 (1990), pp. 1190-1194
[41.]
V. Villena, A. López Encuentra, J. Echave-Sustaeta, et al.
Estudio prospectivo de 1.000 pacientes consecutivos con derrame pleural. Etiología del derrame y características de los pacientes.
Arch Bronconeumol, 38 (2002), pp. 21-26
[42.]
N.A. Maskell, F.V. Gleeson, R.J. Davies.
Standard pleural biopsy versus CTguided cutting-needle biopsy for diagnosis of malignant disease in pleural effusions: a randomised controlled trial.
Lancet, 361 (2003), pp. 1326-1330
[43.]
C. Boutin, J.R. Viallat, P. Cargnino, et al.
Thoracoscopy in malignant pleural effusions.
Am Rev Respir Dis, 124 (1981), pp. 588-592
[44.]
R. Loddenkemper, H. Grosser, A. Gabler, et al.
Prospective evaluation of biopsy methods in the diagnosis of malignant pleural effusions: intrapatient comparison between pleural fluid cytology, blind needle biopsy and thoracoscopy.
Am Rev Respir Dis, 127 (1983), pp. 114
[45.]
V. Villena, A. Lopez-Encuentra, F. Pozo, et al.
Measurement of pleural pressure during therapeutic thoracentesis.
Am J Respir Crit Care Med, 162 (2000), pp. 1534-1538
[46.]
F. Rodríguez-Panadero, V.B. Antony.
Pleurodesis: State of the art.
Eur Respir J, 10 (1997), pp. 1648-1654
[47.]
C.M. Dresler, J. Olak, J.E. Herndon II, et al.
Phase III Intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion.
Chest, 127 (2005), pp. 909-915
[48.]
P. Shaw, R. Agarwal.
Pleurodesis for malignant pleural effusions.
Cochrane Database Syst Rev, (2004),
[49.]
J. Ferrer, J.F. Montes, M.A. Villarino, et al.
Influence of particle size on extrapleural talc dissemination after talc slurry pleurodesis.
Chest, 122 (2002), pp. 1018-1027
[50.]
J.B. Putnam Jr, G.L. Walsh, S.G. Swisher, et al.
Outpatient management of malignant pleural effusion by a chronic indwelling pleural catheter.
Ann Thorac Surg, 69 (2000), pp. 369-375
[51.]
G. López-Abente, V. Hernández-Barrera, M. Pollán, et al.
Municipal pleural cancer mortality in Spain.
Occup Environ Med, 62 (2005), pp. 195-199
[52.]
International Mesothelioma Interest Group.
A proposed new internacional TNM staging system for malignant pleural mesothelioma.
Chest, 108 (1995), pp. 1122-1128
[53.]
D.J. Sugarbaker, R.M. Flores, M.T. Jaklitsch, et al.
Resection margins, extrapleural nodal status, and cell type determine postoperative longterm survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients.
J Thorac Cardiovasc Surg, 117 (1999), pp. 54-65
[54.]
N.J. Vogelzang, J.J. Rusthoven, J. Symanowski, et al.
Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma.
J Clin Oncol, 21 (2003), pp. 2636-2644
[55.]
Enfermedades autoinmunes del tejido conectivo,
[56.]
J. Ancochea Bermúdez, F. Moldenhauer Díaz, M.J. Espinosa de los Monteros.
Manifestaciones pulmonares de las enfermedades del tejido conectivo.
Manual de Neumología y Cirugía Torácica, pp. 817-835
[57.]
M.P. Keane, J.P. Lynch.
Pleuropulmonary manifestations of systemic lupus erythematosus.
Thorax, 55 (2000), pp. 159-166
[58.]
L.P. Pertschuk, L.F. Moccia, Y. Rosen, et al.
Acute pulmonary complications in systemic lupus erythematosus. Immunofluorescence and light microscopic study.
Am J Clin Pathol, 68 (1977), pp. 553-557
[59.]
W.C. Walker, V. Wright.
Rheumatoid pleuritis.
Ann Rheum Dis, 26 (1967), pp. 467-474
[60.]
G.A. Lillington, D.T. Carr, J.G. Mayne.
Rheumatoid pleurisy with effusion.
Arch Intern Med, 128 (1971), pp. 764-768
[61.]
C. Fernández, C. Payá, L. Hernández, et al.
Rheumatoid factor: diagnostic utility in pleural fluid.
Eur Respir J, 22 (2003), pp. 191s
[62.]
B. Naylor.
The pathognomonic cytologic picture of rheumatoid pleuritis.
Acta Cytol, 34 (1990), pp. 465-473
[63.]
P. Faurschou, D. Francis, P. Faarup.
Thoracoscopic, histological, and clinical findings in nine cases of rheumatoid pleural effusion.
Thorax, 40 (1985), pp. 371-375
[64.]
S. Romero-Candeira, C. Fernández, C. Martín, et al.
Influence of diuretics on the concentration of proteins and other components of pleural transudates in patients with heart failure.
Am J Med, 110 (2001), pp. 681-686
[65.]
R.T. Sadikot, J.T. Rogers, D.S. Cheng, et al.
Pleural fluid characteristics of patients with symptomatic pleural effusion after coronary artery bypass graft surgery.
Arch Intern Med, 160 (2000), pp. 2665-2668
[66.]
R.W. Light, J.T. Rogers, J.P. Moyers, et al.
Prevalence and clinical course of pleural effusions at 30 days after coronary artery and cardiac surgery.
Am J Respir Crit Care Med, 166 (2002), pp. 1567-1571
[67.]
R.W. Light.
Pleural effusions after coronary artery bypass graft surgery.
Curr Opin Pulm Med, 8 (2002), pp. 308-311
[68.]
G. Tomaselli, G. Gamsu, M.S. Stulbarg.
Constrictive pericarditis presenting as pleural effusion of unknown origin.
Arch Intern Med, 149 (1989), pp. 201-203
[69.]
C. Fernández, S. Martínez, L. Hernández, et al.
Pleural effusion associated to constrictive pericarditis.
Eur Respir J, 26 (2005), pp. 446s-447s
[70.]
S. Kim, S.A. Sahn.
Postcardiac injury syndrome. An immunologic pleural fluid analysis.
Chest, 109 (1996), pp. 570-572
[71.]
T.J. Stelzner, T.E. King Jr, V.B. Antony, et al.
The pleuropulmonary manifestations of the postcardiac injury syndrome.
Chest, 84 (1983), pp. 383-387
[72.]
S. Romero Candeira, L. Hernández Blasco, M.J. Soler, et al.
Biochemical and cytologic characteristics of pleural effusions secondary to pulmonary embolism.
Chest, 121 (2002), pp. 465-469
[73.]
M.H. Kollef, M.T. McCormack, D.A. Kristo, et al.
Pleural effusion in patients with systemic cholesterol embolization.
Chest, 103 (1993), pp. 792-795
[74.]
P.H. Nielsen, S.B. Jepsen, A.D. Olsen.
Postoperative pleural effusion following upper abdominal surgery.
Chest, 96 (1989), pp. 1133-1135
[75.]
Y. Misawa, K. Fuso, T. Kaegona.
Infectious mediastinitis after cardiac operations: computed tomographic finding.
Ann Thorac Surg, 65 (1998), pp. 622-624
[76.]
J. O’Brien, N. Ettinger.
Pulmonary complications of liver transplantation.
Clin Chest Med, 17 (1996), pp. 99-114
[77.]
J. Ferrer, J. Roldán, A. Román, et al.
Acute and chronic pleural complications in lung transplantation.
J Heart Lung Transplant, 22 (2003), pp. 1217-1225
[78.]
M. Judson, J. Handy, S. Sahn.
Pleural effusion from acute lung rejection.
Chest, 111 (1997), pp. 1128-1130
[79.]
W.M. Alberts, A.J. Salem, D.A. Solomon, et al.
Hepatic hydrothorax cause and management.
Arch Intern Med, 151 (1991), pp. 2383-2388
[80.]
E. Pérez-Amor, C. Almonacid.
Derrame pleural en las enfermedades del aparato digestivo.
Rev Patol Respir, 6 (2003), pp. 57-64
[81.]
A. Cárdenas, T. Kelleher, S. Chopra.
Review article: hepatic hydrothorax.
Aliment Pharmacol Ther, 20 (2004), pp. 271-279
[82.]
J.M. McKenna, A.j. Chandrasekhar, D. Skorton, et al.
The pleuropulmonary complications of pancreatitis.
Chest, 71 (1977), pp. 197-204
[83.]
J.T. Huggins, S.A. Sahn.
Drug-induced pleural disease.
Clin Chest Med, 25 (2004), pp. 141-153
[84.]
American Thoracic Society Documents.
Diagnosis, and Initial Management of Nonmalignant Diseases Related to Asbestos.
Am J Respir Crit Care Med, 170 (2004), pp. 691-715
[85.]
Occupational Disorders of the Lung,
[86.]
O. Dorigo, J. Berek.
Sex cord-stromal tumors of the ovary.
UpTo-Date, V12 (2004),
[87.]
V. Insler, B. Lunenfeld.
Classification and treatment of ovarian hyperstimulation syndrome.
UpToDate, V12 (2004),
[89.]
S. Romero, C. Martín, L. Hernández, et al.
Chylothorax in cirrhosis of the liver: analysis of its frequency and clinical characteristics.
Chest, 114 (1998), pp. 154-159
[91.]
B.A. Staats, R.W. Ellefson, L.L. Budahn, et al.
The lipoprotein profile of chylous and nonchylous pleural effusions.
Mayo Clin Proc, 55 (1980), pp. 700-704
[92.]
R.P. González, M.R. Holevar.
Role of prophylactic antibiotics for tube thoracostomy in chest trauma.
Am Surg, 64 (1998), pp. 617-620
[93.]
F.A. Luchette, P.S. Barrie, M.F. Oswanski, et al.
Practice management guidelines for prophylactic antibiotic use in tube thoracostomy for traumatic hemopneumothorax: the EAST Practice Management Guidelines Work Group. Eastern Association for Trauma.
J Trauma, 48 (2000), pp. 753-757
[94.]
N. Ahmed, D. Jones.
Video-assisted thoracic surgery: state of the art in trauma care.
Injury, 35 (2004), pp. 479-489
[95.]
C. Jerjes-Sánchez, A. Ramírez-Rivera, J.J. Elizalde, et al.
Intrapleural fibrinolysis with streptokinase as an adjunctive treatment in hemotórax and empyema: a multicenter trial.
Chest, 109 (1996), pp. 1514-1519
[96.]
D.M. Meyer, M.E. Jessen, M.A. Wait, et al.
Early evacuation of traumatic retained hemothoraces using thoracoscopy: a prospective, randomized trial.
Ann Thorac Surg, 64 (1997), pp. 1396-1400
Copyright © 2006. Sociedad Española de Neumología y Cirugía Torácica
